JP4748962B2 - Moisturizer, cell activator, whitening agent, and antioxidant - Google Patents

Moisturizer, cell activator, whitening agent, and antioxidant Download PDF

Info

Publication number
JP4748962B2
JP4748962B2 JP2004250999A JP2004250999A JP4748962B2 JP 4748962 B2 JP4748962 B2 JP 4748962B2 JP 2004250999 A JP2004250999 A JP 2004250999A JP 2004250999 A JP2004250999 A JP 2004250999A JP 4748962 B2 JP4748962 B2 JP 4748962B2
Authority
JP
Japan
Prior art keywords
extract
malvanic
added
skin
antioxidant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2004250999A
Other languages
Japanese (ja)
Other versions
JP2006063056A (en
Inventor
規文 木元
由美子 奥村
宏子 菊地
陽一 安田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2004250999A priority Critical patent/JP4748962B2/en
Publication of JP2006063056A publication Critical patent/JP2006063056A/en
Application granted granted Critical
Publication of JP4748962B2 publication Critical patent/JP4748962B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、保湿剤、細胞賦活剤、美白剤、抗酸化剤、皮膚外用剤、及び食品に関する。さらに詳しくは、マルバニッケイ(Cinnamomum daphnoides)の抽出物を含有する細胞賦活剤、美白剤、抗酸化剤、皮膚外用剤、及び食品に関する。 The present invention relates to a humectant, a cell activator, a whitening agent, an antioxidant, a skin external preparation, and a food. More specifically, cell activator containing extract of Malva Nikkei (Cinnamomum daphnoides), whitening agents, antioxidants, skin external preparation, and a food.

加齢、紫外線、ストレスなどによるシワ、シミ、皮膚の弾性低下といった皮膚症状の要因として、乾燥、細胞機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線等による細胞の酸化傷害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索及び配合検討が従来なされてきた。細胞賦活剤としては、ポンカンのエッセンス(特許文献1参照)、美白剤としては、白鶴霊芝の水および/または有機溶媒抽出物(特許文献2参照)、抗酸化剤としては、サルオガセ科サルオガセ属植物の抽出物(特許文献3参照)が知られている。   Causes of skin symptoms such as aging, ultraviolet rays, stress, wrinkles, stains, skin elasticity decrease, dryness, decreased cellular function, melanin production and pigmentation due to ultraviolet rays, decrease or degeneration of dermal matrix components, ultraviolet rays, etc. Examples include oxidative damage. In order to prevent and ameliorate such skin symptoms, search for various active ingredients and formulation studies have been conventionally conducted. As the cell activator, the essence of Ponkan (see Patent Document 1), as the whitening agent, water and / or organic solvent extract of Hakutsuru Reishi (see Patent Document 2), and as the antioxidant, the genus Sarogase Plant extracts (see Patent Document 3) are known.

なお、マルバニッケイの抽出物を有効成分とする保湿剤、細胞賦活剤、美白剤、抗酸化剤、皮膚外用剤、及び食品に関する先行技術は認められなかった。   In addition, the prior art regarding a moisturizer, a cell activator, a whitening agent, an antioxidant, a skin external preparation, and a food containing an extract of malvanickey as an active ingredient was not recognized.

特開2001−131045号公報JP 2001-131045 A 特開2003−89630号公報JP 2003-89630 A 特開平10−182413号公報Japanese Patent Laid-Open No. 10-182413

天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などが皮膚外用剤や飲食品などの分野に幅広く応用されている。しかし、天然由来成分の中には未だその効果が知られていないものも数多く存在し、優れた細胞賦活作用、美白作用、抗酸化作用などを有する有効成分の開発が期待されていた。本発明は、このような有効成分を見出すためになされたものであり、皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、細胞賦活剤、美白剤、抗酸化剤を提供することを目的とする。   Naturally-derived components are known to have various pharmacological and cosmetic effects, and so far many plants and fungi have been widely applied to fields such as external preparations for skin and foods and drinks. However, there are many naturally-derived components whose effects are not yet known, and the development of active ingredients having excellent cell activation, whitening, antioxidant and the like has been expected. The present invention was made in order to find such an active ingredient, and provides a moisturizer, cell activator, whitening agent, and antioxidant that can be widely applied in the fields of external preparations for skin and foods and drinks. For the purpose.

本発明者らは、皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、細胞賦活剤、美白剤、及び抗酸化剤を見出すために、天然由来の種々の物質について検討を行った。その結果、マルバニッケイの抽出物に優れた保湿作用、細胞賦活作用、美白作用、及び抗酸化作用を見出し、さらに検討を重ね、本発明を完成するに至った。すなわち、本発明は、マルバニッケイを有効成分とする保湿剤、細胞賦活剤、美白剤、及び抗酸化剤、並びにマルバニッケイの1種または2種以上の植物の抽出物を配合する皮膚外用剤、及び食品を提供するものである。   In order to find a moisturizer, a cell activator, a whitening agent, and an antioxidant that can be widely applied to fields such as external preparations for skin and foods and drinks, the present inventors have studied various substances derived from nature. It was. As a result, an excellent moisturizing action, cell activation action, whitening action and antioxidant action were found in the extract of malvanickey, and further investigations were made to complete the present invention. That is, the present invention is a skin external preparation containing a moisturizer, a cell activator, a whitening agent, an antioxidant, and an extract of one or more plants of malvanic acid, which contains malvanic acid as an active ingredient, And providing food.

本発明によれば、優れた効果を有する保湿剤、細胞賦活剤、美白剤、及び抗酸化剤を提供することができ、これらを皮膚外用剤や食品等の組成物に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミといった種々の皮膚症状の防止や改善に優れた効果を発揮する様々な組成物を提供することができる。   According to the present invention, it is possible to provide a moisturizer, a cell activator, a whitening agent, and an antioxidant having an excellent effect, and by blending them in a composition such as a skin external preparation or food, It is possible to provide various compositions that exhibit an excellent effect in preventing and improving various skin symptoms such as talmi, skin firmness, spots, and kusumi.

本発明の原料として用いられる植物であるマルバニッケイ(Cinnamomum daphnoides)は、クスノキ科クスノキ属の植物であり、温暖な地域の海岸沿いに生育する常緑木である。 Malvanica ( Cinnamum daphnoides ), which is a plant used as a raw material of the present invention, is an evergreen tree that grows along the coast of a temperate region.

マルバニッケイを使用する際は、そのまま粉砕して使用することもできるが、抽出物を用いるとよい。抽出には、マルバニッケイの幹、枝、葉、花、種子、樹皮、樹液、根、茎、芽などのいずれの部位を用いても構わないが、簡便に利用するには、葉、茎、種子を用いるとよく、有効性の点からは葉や茎を用いるとよい。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌や抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。   When using malvanic silicate, it can be pulverized as it is, but an extract may be used. For extraction, any part of the trunk, branch, leaf, flower, seed, bark, sap, root, stem, bud, etc. of malvanica may be used. Seeds are preferably used, and leaves and stems are preferably used from the viewpoint of effectiveness. In the extraction, it may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, the mixture may be homogenized in stirring or an extraction solvent. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but it is appropriate to set it to about 1 hour to 14 days.

抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール、1、3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール、エチルエーテル、プロピルエーテル等のエーテル類、酢酸ブチル、酢酸エチル等のエステル類、アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界流体や亜臨界流体を用いてもよい。   Extraction solvents include water, lower alcohols such as methanol, ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether. And solvents such as esters such as butyl acetate and ethyl acetate, and ketones such as acetone and ethyl methyl ketone can be used, and one or more of these can be selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical fluids and subcritical fluids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.

マルバニッケイの上記溶媒による抽出物は、そのままでも使用することができるが、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもでき、これらの生理作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理やカラムクロマトグラフィー等による分画処理を行った後に用いてもよい。マルバニッケイの前記抽出物やその処理物及び分画物は、各処理及び分画後に凍結乾燥し、用時に溶媒に溶解して用いることもできる。   Although the extract of malvanic acid from the above solvent can be used as it is, it can be used by re-dissolving the concentrated and dried product in water or a polar solvent, as long as these physiological functions are not impaired. It may be used after performing purification treatment such as decolorization, deodorization, and desalting, and fractionation treatment by column chromatography. The said extract of malvanic acid, its processed material, and a fraction are freeze-dried after each process and fractionation, It can also be melt | dissolved and used for a solvent at the time of use.

マルバニッケイの抽出物は、優れた保湿作用、細胞賦活作用、美白作用、及び抗酸化作用を有し、保湿剤、細胞賦活剤、美白剤、抗酸化剤、皮膚外用剤、及び食品として利用することができる。また、マルバニッケイの抽出物を有効成分とする保湿剤、細胞賦活剤、美白剤、抗酸化剤は、皮膚に外用するだけではなく、毛髪に利用することや経口摂取も可能であり、食品、飲料、あるいは医薬品などにも応用することが可能である。   Malvanica extract has excellent moisturizing action, cell activation action, whitening action and antioxidant action, and is used as a moisturizing agent, cell activator, whitening agent, antioxidant, external skin preparation, and food. be able to. In addition, moisturizers, cell activators, whitening agents, and antioxidants that contain malvanica extract as an active ingredient can be used not only for the skin but also for hair and can be taken orally. It can be applied to beverages or pharmaceuticals.

マルバニッケイの抽出物を有効成分とする保湿剤は、皮膚や毛髪に対して優れた保湿作用を発揮し、特に皮膚に対する保湿効果が高い。   A moisturizing agent containing an extract of malvanickey as an active ingredient exhibits an excellent moisturizing action on the skin and hair, and has a particularly high moisturizing effect on the skin.

マルバニッケイの抽出物を有効成分とする細胞賦活剤は、種々の細胞に対して優れた賦活作用を発揮するが、特に真皮線維芽細胞に対して優れた効果を発揮する。   A cell activator comprising an extract of malvanickey as an active ingredient exerts an excellent activation action on various cells, but particularly exhibits an excellent effect on dermal fibroblasts.

マルバニッケイの抽出物を有効成分とする美白剤は、シミ・ソバカスといった色素沈着症状の改善に効果を発揮し、特にチロシナーゼ活性阻害に基づくメラニンの産生抑制に対して優れた効果を発揮する。   A whitening agent containing an extract of malvanickey as an active ingredient is effective in improving pigmentation symptoms such as stains and buckwheat, and is particularly effective in suppressing melanin production based on inhibition of tyrosinase activity.

マルバニッケイの抽出物を有効成分とする抗酸化剤は、優れた抗酸化作用を発揮するが、特にフリーラジカル消去作用に優れた効果を発揮する。   Antioxidants containing an extract of malvanic silicate as an active ingredient exhibit an excellent antioxidant action, but exhibit an excellent effect particularly on free radical scavenging action.

また、マルバニッケイの抽出物を皮膚外用剤に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミ、乾燥、小じわ等の皮膚症状の防止・改善に優れた効果を発揮する皮膚外用剤を得ることができ、老化防止改善用皮膚外用剤や美白用皮膚外用剤としても用いることができる。さらに、マルバニッケイの抽出物は、美容、健康維持、又は栄養補給を目的とするような食品や飲料にも用いることもできる。   In addition, the skin external preparation that exhibits an excellent effect in the prevention and improvement of skin symptoms such as wrinkles, tarmi, skin firmness, spots, kumi, dryness, fine wrinkles, etc. And can also be used as a skin external preparation for improving aging prevention and a skin external preparation for whitening. Furthermore, the extract of malvanickey can also be used for foods and beverages for the purpose of beauty, health maintenance or nutritional supplementation.

マルバニッケイの抽出物を皮膚外用剤に配合する際の配合量は、皮膚外用剤の種類や使用目的等によって調整することができるが、効果や安定性などの点から、全量に対して0.0001〜50.0重量%が好ましく、より好ましくは、0.001〜25.0重量%である。   The blending amount of the extract of malvanickey in the skin external preparation can be adjusted depending on the type of skin external preparation and the purpose of use. The amount is preferably 0001 to 50.0% by weight, more preferably 0.001 to 25.0% by weight.

マルバニッケイの抽出物を配合する皮膚外用剤の剤型は任意であり、例えば、ローションなどの可溶化系、クリームや乳液などの乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤と共に充填したエアゾール、軟膏剤、粉末、顆粒などの種々の剤型で提供することもできる。   The dosage form of the external preparation for skin containing the extract of malvanica is arbitrary, and can be provided as a solubilizing system such as lotion, an emulsifying system such as cream or emulsion, and a dispersing system such as calamine lotion. Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders and granules filled with a propellant.

なお、マルバニッケイの抽出物を配合する皮膚外用剤には、マルバニッケイの抽出物の他に、必要に応じて、通常医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料に配合される、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、洗浄剤、紫外線吸収剤、増粘剤、薬剤、香料、樹脂、防菌防黴剤、アルコール類等を適宜配合することができる。また、本発明の効果を損なわない範囲において、他の細胞賦活剤、美白剤、抗酸化剤との併用も可能である。   In addition to the extract of malvanickey, the external preparation for skin blended with the extract of malvanickey is usually used for pharmaceuticals, quasi-drugs, skin cosmetics, hair cosmetics and cleansing agents as needed. Blended oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, detergents, UV absorbers, thickeners, drugs, perfumes, resins, antibacterial and antifungal agents, alcohols, etc. can do. Moreover, in the range which does not impair the effect of this invention, combined use with another cell activator, whitening agent, and antioxidant is also possible.

以下に、マルバニッケイの抽出物の製造例、各作用を評価するための試験、皮膚外用剤や食品としての処方例、使用試験についてさらに詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。   In the following, the production example of the extract of malvanickey, the test for evaluating each action, the formulation example as a skin external preparation and food, and the use test will be described in more detail, but the technical scope of the present invention is based on this. It is not limited at all.

[製造例1]
マルバニッケイの全草の乾燥粉砕物1kgに50重量%エタノール水溶液を10リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、マルバニッケイ抽出物を得た。
[Production Example 1]
10 kg of a 50 wt% aqueous ethanol solution was added to 1 kg of a dry pulverized whole plant of malvanickey and immersed for 7 days at room temperature. The extract was collected by filtration, and after removing the solvent, a malvanic extract was obtained.

[製造例2]
マルバニッケイの全草の乾燥粉砕物1kgに水を9リットル加え、90℃にて6時間還流して抽出した。抽出液をろ過して回収し、溶媒を除去した後、マルバニッケイ抽出物を得た。
[Production Example 2]
Nine liters of water was added to 1 kg of dry pulverized whole of malvanickey and extracted by refluxing at 90 ° C. for 6 hours. The extract was collected by filtration, and after removing the solvent, a malvanic extract was obtained.

[製造例3]
マルバニッケイの全草の乾燥粉砕物1kgにメタノールを9リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、マルバニッケイ抽出物を得た。
[Production Example 3]
Nine liters of methanol was added to 1 kg of dry pulverized whole of malvanickey and soaked at room temperature for 7 days. The extract was collected by filtration, and after removing the solvent, a malvanic extract was obtained.

[製造例4]
超臨界抽出装置にマルバニッケイの全草を投入し、40℃において15MPaの気圧下で二酸化炭素の超臨界流体を用いて抽出した。抽出物を回収し、マルバニッケイ抽出物を得た。
[Production Example 4]
The whole plant of malvanickey was put into a supercritical extraction apparatus, and extraction was performed using a supercritical fluid of carbon dioxide at 40 ° C. under a pressure of 15 MPa. The extract was collected to obtain a malvanic extract.

まず、マルバニッケイ抽出物の真皮線維芽細胞の賦活作用について示す。試料には、マルバニッケイの葉と茎の混合物を製造例1と製造例4により抽出したものをそれぞれ試料1,2として評価を行った。   First, it shows about the activation effect | action of a dermal fibroblast of a malvanic extract. Samples obtained by extracting a mixture of malvanic leaves and stems according to Production Example 1 and Production Example 4 were evaluated as Samples 1 and 2, respectively.

評価は、以下の手順で行った。正常ヒト真皮線維芽細胞を1ウェル当たり2.0×10個となるように96穴マイクロプレートに播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1%のウシ胎児血清を添加したものを用いた。24時間培養後、任意の濃度の試料を添加した試験培地に交換し、さらに48時間培養した。次いで3−(4,5−ジメチル−2−チアゾリル)−2,5−ジフェニルテトラゾリウムブロミド(MTT)を400μg/mL含有する培地に交換して2時間培養し、テトラゾリウム環の開環により生じるフォルマザンを2−プロパノールにて抽出し、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に濁度として650nmにおける吸光度を測定し、両測定値の差により細胞賦活作用を評価した。評価結果を、試料無添加のブランクにおける細胞賦活作用を100とした相対値にて表1に示す。なお、表中の*及び**は、t検定における有意確率P値に対し、有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**で表したものである。 The evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 1% fetal bovine serum. After culturing for 24 hours, the culture medium was replaced with a test medium to which a sample having an arbitrary concentration was added, and further cultured for 48 hours. Subsequently, the medium containing 400 μg / mL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) was exchanged and cultured for 2 hours. Formazan generated by the opening of the tetrazolium ring was removed. Extraction was performed with 2-propanol, and absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values. The evaluation results are shown in Table 1 as relative values with the cell activation effect in the blank with no sample as 100. In the table, * and ** indicate a significance probability of less than 5% (P <0.05) with respect to the significance probability P value in the t test, and a significance probability of less than 1% (P <0.01). It is represented by **.

Figure 0004748962
Figure 0004748962

表1より明らかなように、マルバニッケイ抽出物を添加した培地では、有意な真皮線維芽細胞賦活作用が認められた。特に、試料1を0.25〜1.0mg/mL,試料2を0.5〜1.0μg/mL添加した場合には、ブランクと比較して、危険率1%未満で有意な真皮線維芽細胞賦活作用が認められた。このことから、マルバニッケイ抽出物は、優れた真皮線維芽細胞賦活作用を有することが明らかとなった。   As is clear from Table 1, a significant dermal fibroblast activation effect was observed in the medium to which the malvanic extract was added. In particular, when 0.25 to 1.0 mg / mL of sample 1 and 0.5 to 1.0 μg / mL of sample 2 are added, the dermal fibroblasts are significant at a risk rate of less than 1% compared to the blank. A cell activation effect was observed. From this, it was revealed that the malvanic extract has an excellent dermal fibroblast activation effect.

次に、マルバニッケイ抽出物のメラニン産生抑制作用の評価を示す。試料には、マルバニッケイの葉と茎の混合物を製造例1と製造例4により抽出したものをそれぞれ試料1,2として評価を行った。   Next, the evaluation of the melanin production inhibitory effect of the malvanic extract is shown. Samples obtained by extracting a mixture of malvanic leaves and stems according to Production Example 1 and Production Example 4 were evaluated as Samples 1 and 2, respectively.

評価は、以下の手順で行った。B16マウスメラノーマF0ストレイン(B16F0)細胞を35mmディッシュに1ディッシュあたり2000個にて播種した。24時間培養後、任意の濃度の試料を添加した5重量%ウシ胎児血清(FCS)添加ダルベッコ改変イーグル培地(DMEM)に交換した。7日間培養後、0.25%トリプシンを用いて細胞を回収し、1.5mLマイクロチューブに移して遠心操作して細胞沈殿物を得た。さらに、試料を添加した培地の代わりに、ダルベッコ改変イーグル培地(DMEM)に5重量%ウシ胎児血清(FCS)を添加したものをブランクとし、同様に目視判定を行った。また、目視判定は、表2に示す通り、5段階評価によって行った。表3に判定の結果を示した。   The evaluation was performed according to the following procedure. B16 mouse melanoma F0 strain (B16F0) cells were seeded in a 35 mm dish at 2000 cells per dish. After culturing for 24 hours, the culture medium was replaced with Dulbecco's modified Eagle medium (DMEM) supplemented with 5 wt% fetal calf serum (FCS) to which a sample of an arbitrary concentration was added. After culturing for 7 days, the cells were collected using 0.25% trypsin, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate. Furthermore, instead of the medium to which the sample was added, Dulbecco's modified Eagle medium (DMEM) to which 5 wt% fetal calf serum (FCS) was added was used as a blank, and visual determination was similarly performed. Further, as shown in Table 2, the visual judgment was performed by a five-step evaluation. Table 3 shows the determination results.

Figure 0004748962
Figure 0004748962

Figure 0004748962
Figure 0004748962

表3より明らかなように、試料1を0.01〜0.1mg/mL,試料2を0.05〜1.0μg/mL添加した培地を用いた場合に、ほとんど黒化は認められず、マルバニッケイ抽出物は、優れたメラニン産生抑制作用を有することが明らかとなった。   As is clear from Table 3, when a medium containing 0.01 to 0.1 mg / mL of sample 1 and 0.05 to 1.0 μg / mL of sample 2 was used, almost no blackening was observed, It has been clarified that the malvanic extract has an excellent inhibitory effect on melanin production.

次に、マルバニッケイ抽出物の抗酸化作用について示す。試料には、マルバニッケイの葉と茎の混合物を製造例1と製造例4により抽出したものをそれぞれ試料1,2として評価を行った。   Next, it shows about the antioxidant effect of a malvanic acid extract. Samples obtained by extracting a mixture of malvanic leaves and stems according to Production Example 1 and Production Example 4 were evaluated as Samples 1 and 2, respectively.

評価は、以下の手順で行った。50重量%エタノール水溶液にて任意の濃度に希釈したマルバニッケイ抽出物溶液を96穴マイクロプレートに100μL添加した。次に、0.2mMの濃度になるようにエタノールにて調製した1、1−ジフェニル−2−ピクリルヒドラジル(DPPH)溶液を96穴マイクロプレートに100μL添加した。攪拌しながら暗所に放置し、24時間後に516nmの吸光度を測定した。試料が無添加のブランクの吸光度を(A)、試料を添加したときの吸光度を(B)としたとき、式(1)の値をラジカル消去率とした。評価結果を表4に示した。
式(1) {1−(B)/(A)}×100(%)
The evaluation was performed according to the following procedure. 100 μL of a malvanic acid extract solution diluted to an arbitrary concentration with a 50 wt% aqueous ethanol solution was added to a 96-well microplate. Next, 100 μL of a 1,1-diphenyl-2-picrylhydrazyl (DPPH) solution prepared in ethanol to a concentration of 0.2 mM was added to a 96-well microplate. The mixture was left in the dark with stirring, and the absorbance at 516 nm was measured after 24 hours. When the absorbance of the blank with no sample added was (A) and the absorbance when the sample was added was (B), the value of formula (1) was defined as the radical elimination rate. The evaluation results are shown in Table 4.
Formula (1) {1- (B) / (A)} × 100 (%)

Figure 0004748962
Figure 0004748962

表4より明らかなように、マルバニッケイ抽出物はラジカル消去に基づく抗酸化作用を有することが分かった。   As is clear from Table 4, it was found that the malvanic extract had an antioxidant action based on radical scavenging.

続いて、本発明に係るマルバニッケイ抽出物を配合した皮膚外用剤の処方例を示す。   Then, the prescription example of the skin external preparation which mix | blended the malvanica extract which concerns on this invention is shown.

[処方例1]乳液
(1)スクワラン 10.0(重量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 53.85
(11)アルギニン(1重量%水溶液) 20.0
(12)マルバニッケイ抽出物[製造例1] 5.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、均一に混合する。
[Formulation Example 1] Emulsion (1) Squalane 10.0 (wt%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water 53.85
(11) Arginine (1 wt% aqueous solution) 20.0
(12) Malvanickey extract [Production Example 1] 5.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After emulsification, start cooling and add (11) and (12) sequentially and mix uniformly.

[処方例2]化粧水
(1)エタノール 15.0(重量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 78.38
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)マルバニッケイ抽出物[製造例3] 5.0
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
[Prescription Example 2] Lotion (1) Ethanol 15.0 (wt%)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 78.38
(5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Malvanic extract (Production Example 3) 5.0
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then sufficiently stirred, (9) is added and mixed uniformly.

[処方例3]クリーム
(1)スクワラン 10.0(重量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20重量%水溶液) 15.0
(10)精製水 40.7
(11)カルボキシビニルポリマー(1重量%水溶液) 15.0
(12)マルバニッケイ抽出物[製造例1] 1.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Prescription Example 3] Cream (1) Squalane 10.0 (% by weight)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20% by weight aqueous solution) 15.0
(10) Purified water 40.7
(11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Malvanickey extract [Production Example 1] 1.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After the emulsification is completed, add (11), start cooling, add (12) at 40 ° C., and mix uniformly.

[処方例4]美容液
(1)精製水 27.45(重量%)
(2)グリセリン 10.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1重量%水溶液) 17.5
(5)アルギン酸ナトリウム(1重量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N-ラウロイル-L-グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1、3−ブチレングリコール 10.0
(15)L−アルギニン(10重量%水溶液) 2.0
(16)マルバニッケイ抽出物[製造例1] 5.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)を加え、均一に混合する。
[Formulation Example 4] Cosmetic liquid (1) Purified water 27.45 (% by weight)
(2) Glycerin 10.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1 wt% aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by weight aqueous solution) 2.0
(16) Malvanickey extract [Production Example 1] 5.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. Cooling is started after completion of emulsification, and (15) is added at 50 ° C. Cool further to 40 ° C, add (16) and mix evenly.

[処方例5]水性ジェル
(1)カルボキシビニルポリマー 0.5(重量%)
(2)精製水 86.7
(3)水酸化ナトリウム(10重量%水溶液) 0.5
(4)エタノール 10.0
(5)パラオキシ安息香酸メチル 0.1
(6)香料 0.1
(7)マルバニッケイ抽出物[製造例4] 2.0
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
[Formulation Example 5] Aqueous gel (1) Carboxyvinyl polymer 0.5 (% by weight)
(2) Purified water 86.7
(3) Sodium hydroxide (10% by weight aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Malvanickey extract [Production Example 4] 2.0
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 0.1
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.

[処方例6]クレンジング料
(1)スクワラン 81.0(重量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 3.0
(4)マルバニッケイ抽出物[製造例4] 1.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
[Formulation Example 6] Cleansing Fee (1) Squalane 81.0 (wt%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water 3.0
(4) Malvanic extract (Production Example 4) 1.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.

[処方例7]洗顔フォーム
(1)ステアリン酸 16.0(重量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 36.5
(8)マルバニッケイ抽出物[製造例3] 1.0
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、40℃にて(8)を加え、均一に混合する。
[Prescription Example 7] Face-wash foam (1) Stearic acid 16.0 (% by weight)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) Purified water 36.5
(8) Malvanic extract (Production Example 3) 1.0
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase components. Cooling is started, and (8) is added at 40 ° C. and mixed uniformly.

[処方例8]メイクアップベースクリーム
(1)スクワラン 10.0(重量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 69.4
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)マルバニッケイ抽出物[製造例2] 1.2
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 8] Make-up base cream (1) Squalane 10.0 (% by weight)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Purified water 69.4
(8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Malvanickey extract [Production Example 2] 1.2
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[処方例9]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(重量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1、3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 57.4
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)マルバニッケイ抽出物[製造例4] 1.0
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却を開始し、40℃にて(16)と(17)の成分を順次加え、均一に混合する。
[Formulation Example 9] Emulsion foundation (1) Methylpolysiloxane 2.0 (wt%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Purified water 57.4
(11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Malvanic extract (Production Example 4) 1.0
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. Add oil phase ingredients and emulsify. Cooling is started after the emulsification is completed, and components (16) and (17) are sequentially added at 40 ° C. and mixed uniformly.

[処方例10]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(重量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1、3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)マルバニッケイ抽出物[製造例1] 1.0
(11)精製水 47.4
(12)香料 0.1
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(10)を(11)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Formulation Example 10] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (% by weight)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Malvanickey extract [Production Example 1] 1.0
(11) Purified water 47.4
(12) Fragrance 0.1
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C., and gradually add to (4) heated to 50 ° C. with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melt | dissolved at 70 degreeC. (7) to (10) are added to the remainder of (11) heated and dissolved at 70 ° C. while stirring and emulsified with a homomixer. Cooling is started after completion of emulsification, and (12) is added at 40 ° C. and mixed uniformly.

[処方例11]パック
(1)精製水 58.9(重量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)マルバニッケイ抽出物[製造例2] 5.0
(7)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)と(7)を加え、均一に混合する。
[Prescription Example 11] Pack (1) Purified water 58.9 (% by weight)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Malvanickey extract [Production Example 2] 5.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After uniformly dissolving, add (4) and (5), and start cooling while stirring. Cool to 40 ° C, add (6) and (7) and mix uniformly.

[処方例12]入浴剤
(1)香料 0.3(重量%)
(2)マルバニッケイ抽出物[製造例1] 1.0
(3)炭酸水素ナトリウム 50.0
(4)硫酸ナトリウム 48.7
製法:(1)〜(4)を均一に混合する。
[Prescription Example 12] Bath agent (1) Fragrance 0.3 (% by weight)
(2) Malvanickey extract [Production Example 1] 1.0
(3) Sodium bicarbonate 50.0
(4) Sodium sulfate 48.7
Production method: (1) to (4) are mixed uniformly.

[処方例13]ヘアーワックス
(1)ステアリン酸 3.0(重量%)
(2)マイクロクリスタリンワックス 2.0
(3)セチルアルコール 3.0
(4)高重合メチルポリシロキサン 2.0
(5)メチルポリシロキサン 5.0
(6)ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7)パラオキシ安息香酸メチル 0.1
(8)1、3−ブチレングリコール 7.5
(9)アルギニン 0.7
(10)精製水 73.6
(11)マルバニッケイ抽出物[製造例1] 2.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解後する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 13] Hair wax (1) Stearic acid 3.0 (% by weight)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) Purified water 73.6
(11) Malvanic extract (Production Example 1) 2.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.

[処方例14]ヘアートニック
(1)エタノール 50.0(重量%)
(2)精製水 48.9
(3)マルバニッケイ抽出物[製造例3] 1.0
(4)香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
[Prescription Example 14] Hair artic (1) Ethanol 50.0 (% by weight)
(2) Purified water 48.9
(3) Malvanic extract (Production Example 3) 1.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.

[処方例15]飲料
(1)マルバニッケイ抽出物[製造例1] 8.0(重量%)
(2)エリスリトール 1.0
(3)クエン酸 0.1
(4)ステビア 0.01
(5)精製水 90.89
製法:(1)〜(5)を均一に混合する。
[Prescription Example 15] Beverage (1) Malvanic extract [Production Example 1] 8.0 (% by weight)
(2) Erythritol 1.0
(3) Citric acid 0.1
(4) Stevia 0.01
(5) Purified water 90.89
Production method: (1) to (5) are mixed uniformly.

次に、マルバニッケイ抽出物を配合した処方を用いて使用試験を行い、乾燥による肌荒れについて改善効果を評価した。その際、処方例1に示した乳液の処方に表5に記載するマルバニッケイ抽出物をそれぞれ配合し、実施例1〜3として使用試験を行った。また、マルバニッケイ抽出物を精製水に代替し、比較例1として同時に使用試験を行った。   Next, a use test was conducted using a prescription blended with a malvanickey extract, and the effect of improving the rough skin due to drying was evaluated. At that time, the malvanic acid extract described in Table 5 was blended in the emulsion formulation shown in Formulation Example 1, and the use test was conducted as Examples 1-3. Moreover, the use test was simultaneously performed as the comparative example 1 by substituting the malvanic silicate extract with purified water.

Figure 0004748962
Figure 0004748962

各試料について、肌荒れ症状が顕著に認められる30〜50才代の乾燥肌の女性パネラー20名をそれぞれ一群とし、ブラインドにて1週間使用させ、使用前後の皮膚状態の変化を観察して評価した。皮膚症状の指標として、乾燥による肌荒れについて、「改善」、「やや改善」、「変化なし」の三段階で評価し、表6に各評価を得たパネラー数にて示した。   For each sample, 20 female panelists with dry skin in their 30s to 50s whose skin symptom was remarkably recognized were grouped and used blindly for 1 week, and the skin condition before and after use was observed and evaluated. . As an index of skin symptom, rough skin due to dryness was evaluated in three stages of “improved”, “slightly improved”, and “no change”.

Figure 0004748962
Figure 0004748962

表6より、マルバニッケイ抽出物を含有しない比較例使用群においては、6割以上のパネラーに改善は認められなかったが、マルバニッケイ抽出物を配合した実施例使用群においては、6割以上のパネラーに明確な肌荒れの改善が認められた。このことから、マルバニッケイ抽出物は優れた保湿効果を有することが明らかとなった。
From Table 6, in the comparative example use group which does not contain a malvanic extract, improvement was not recognized in 60% or more of panelists, but in the example use group which mix | blended the malvanic extract, 60% or more A clear improvement in rough skin was recognized by the panelists. From this, it was revealed that the malvanic silicate extract has an excellent moisturizing effect.

Claims (1)

マルバニッケイの抽出物を有効成分とすることを特徴とする美白剤A whitening agent characterized by comprising an extract of malvanickey as an active ingredient.
JP2004250999A 2004-08-30 2004-08-30 Moisturizer, cell activator, whitening agent, and antioxidant Active JP4748962B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004250999A JP4748962B2 (en) 2004-08-30 2004-08-30 Moisturizer, cell activator, whitening agent, and antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004250999A JP4748962B2 (en) 2004-08-30 2004-08-30 Moisturizer, cell activator, whitening agent, and antioxidant

Publications (2)

Publication Number Publication Date
JP2006063056A JP2006063056A (en) 2006-03-09
JP4748962B2 true JP4748962B2 (en) 2011-08-17

Family

ID=36109838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004250999A Active JP4748962B2 (en) 2004-08-30 2004-08-30 Moisturizer, cell activator, whitening agent, and antioxidant

Country Status (1)

Country Link
JP (1) JP4748962B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4515425B2 (en) * 2006-09-20 2010-07-28 株式会社ノエビア Moisturizer, cell activator, whitening agent, and antioxidant
TWI481422B (en) * 2010-02-26 2015-04-21 Univ Kaohsiung Medical Composition for inhibiting melanogenesis and use thereof
JP2020094000A (en) * 2018-12-13 2020-06-18 株式会社ノエビア Skin external preparation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124522A (en) * 1984-07-13 1986-02-03 Kao Corp Inhibitor composition for formation of skin peroxylipid
JP3862765B2 (en) * 1994-04-11 2006-12-27 株式会社ナリス化粧品 Melanin inhibitor
JPH0940597A (en) * 1994-12-13 1997-02-10 Natl Sci Council Cinnamophilin, its derivative, their production, platelet aggregation inhibitor, tracheorelaxant, antioxidant and vasorelaxant
JPH0920634A (en) * 1995-07-04 1997-01-21 Shiseido Co Ltd Whitening skin preparation for external use
JPH10287582A (en) * 1997-04-09 1998-10-27 Ogawa Koryo Kk Suppressant for liberation of histamine comprising bark extract
JP4831849B2 (en) * 1997-04-23 2011-12-07 三省製薬株式会社 Active oxygen scavenger and its use
JP5142113B2 (en) * 1997-07-31 2013-02-13 三省製薬株式会社 Melanin production inhibitor and use thereof
JPH11171758A (en) * 1997-12-12 1999-06-29 Maruzen Seiyaku Kk Elastase inhibitor and preparation for external use for skin
JP2001226218A (en) * 2000-02-17 2001-08-21 Ichimaru Pharcos Co Ltd Cosmetic composition containing plant steam distillation water
JP2002161042A (en) * 2000-11-27 2002-06-04 Soda Aromatic Co Ltd Antioxidant
JP4577868B2 (en) * 2001-10-23 2010-11-10 株式会社資生堂 Matrix metalloprotease activity inhibitor

Also Published As

Publication number Publication date
JP2006063056A (en) 2006-03-09

Similar Documents

Publication Publication Date Title
JP5557414B2 (en) Moisturizer, cell activator, and whitening agent
JP5062980B2 (en) Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter
JP5312731B2 (en) Topical skin preparation
JP4689215B2 (en) Moisturizer, cell activator, whitening agent, and collagenase inhibitor
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4050727B2 (en) Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation
JP2007277100A (en) Humectant, cell activator, dermal fibroblast activator, epidermal cell activator, collagen production accelerator, antioxidant, anti-aging agent, beautifully whitening agent or melanin production inhibitor
JP4994684B2 (en) Moisturizer, cell activator, and antioxidant
JP4931452B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4970442B2 (en) Whitening agent
JP4515423B2 (en) Moisturizer, cell activator, and antioxidant
JP4515425B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP3754025B2 (en) Cell activator, antioxidant, and skin external preparation
JP4334956B2 (en) Cell activators, whitening agents, and antioxidants
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP4291647B2 (en) Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation
JP4916150B2 (en) Moisturizer, cell activator, antioxidant, and skin external preparation,
JP4869638B2 (en) Cell activator, whitening agent, antioxidant, amylase inhibitor, and humectant
JP4936754B2 (en) Moisturizer, cell activator, and collagenase inhibitor
JP3734222B2 (en) External preparation for skin, cell activator, and antioxidant
JP5009544B2 (en) Moisturizer, cell activator, antioxidant, and collagenase inhibitor
JP5013726B2 (en) Moisturizer, cell activator, antioxidant, and collagenase inhibitor
JP4245862B2 (en) Topical skin preparation
JP4050674B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, elastin production promoter, antioxidant, and external preparation for skin
JP4033349B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, decorin production promoter, antioxidant, and external preparation for skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070703

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100713

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100910

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101130

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110131

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110517

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110517

R150 Certificate of patent or registration of utility model

Ref document number: 4748962

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140527

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250